Chapters
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 | Beclometasone and formoterol (Fostair® Bibecfo® Luforbec®) | Fostair Aerosol inhalation - Beclometasone dipropionate 100 micrograms & Formoterol fumarate 6 micrograms | |
| Beclometasone and formoterol (Fostair® NEXThaler®) | Fostair Aerosol inhalation - Beclometasone dipropionate 100 micrograms & Formoterol fumarate 6 micrograms | |
| Beclometasone CFC free MDI (QVAR brand) | For existing patients only | |
| Beclometasone dipropionate | ||
| Beclometasone with Formoterol & Glycopyrronium (Trimbow®) | For COPD and asthma | |
| Budenoside and Formoterol (Symbicort) | For asthma only. Non-formulary for COPD. | |
| Budenoside nebulised | ||
| Budesonide inhaler | As per BTS/SIGN asthma guidelines | |
 | Ciclesonide | Initiation by a respiratory specialist. Supported by a RICaD. | |
| Flucitasone and salmeterol | ||
| Flucitasone and salmeterol (Seretide®) | For existing patients, for paediatric use only (i.e. up to 18 years of age) - APC listing of current formulary brands | |
 | Flucitasone inhaler (Flixotide) evohaler 125 / Fluticasone accuhaler 250 | For paediatric use only | |
| Flucitasone inhaler (Flixotide) evohaler 50 / Fluticasone accuhaler 50, 100 | For paediatric use only | |
| Fluticasone | ||
| Fluticasone and formoterol (Flutiform®) | ||
| Fluticasone furoate & vilanterol (Relvar Ellipta®) | 92mcg/22mcg - In line with COPD Guidance | |
| Fluticasone nebulised (Flixotide) | ||
| Fluticasone with Umeclidium and Vilanterol (Trelegy Ellipta) |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
